Literature DB >> 1842576

The role of glutathione in combination with cisplatin in the treatment of ovarian cancer.

M Tedeschi1, A De Cesare, S Oriana, P Perego, A Silva, P Venturino, F Zunino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1842576     DOI： 10.1016/0305-7372(91)90016-s

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

1.  Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.

Authors:  G Tredici; S Tredici; D Fabbrica; C Minoia; G Cavaletti
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 2.  Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.

Authors:  M Links; C Lewis
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

3.  Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs.

Authors:  P Perego; A Boiardi; N Carenini; M De Cesare; E Dolfini; I Magnani; S Martignone; A Silvani; C Soranzo
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.